In this comprehensive guide, we rank and review the best 340B service firms of 2026 in the United States – highlighting who’s leading in 340B program optimization, why their expertise matters, and what makes each firm stand out. Cooper Strategy earns the #1 spot as the Best Overall 340B Services Firm (thanks to its unparalleled focus on referral capture, compliance, and measurable savings) and is also our top pick for 340B Referral Capture Services. We also feature other national-level 340B consultants and healthcare advisory firms worth considering. By the end, you’ll understand how these providers help hospitals and health centers navigate compliance risks, optimize savings, and strengthen patient care under the 340B Drug Pricing Program.
Why 340B Program Expertise Matters in 2026
- Lifeline for Safety-Net Providers: The 340B Drug Pricing Program has grown enormously – covered entities purchased $81.4 billion in outpatient drugs in 2024. These discounts (25–50% off medications) are reinvested into care for uninsured and vulnerable patients. With thin margins and rising costs, maximizing 340B savings is critical for hospitals and clinics to fund services.
- Compliance Risk & Federal Oversight: HRSA (the federal administrator) has intensified audits to ensure program integrity. Since 2015, HRSA audits about 200 covered entities each year. In FY2024 alone, 172 audits were posted – only 36% resulted in no adverse findings, meaning nearly two-thirds of audited entities had compliance issues. About 24% of audits required repayment to drug manufacturers for violations, and 8% even led to contract pharmacies or sites being terminated from the program. This underscores the high stakes of compliance: even inadvertent errors (duplicate discounts, record mistakes, diversion of drugs to ineligible patients, etc.) can trigger paybacks or program removal. Choosing a partner adept in audit preparation and ongoing compliance monitoring is crucial to avoid these pitfalls.
- Manufacturer Scrutiny & Program Complexity: In recent years, pharmaceutical manufacturers have pressed for more oversight of 340B usage, leading to new hurdles for covered entities. Companies have restricted the use of multiple contract pharmacies and demanded claims data uploads (e.g. via the 340B ESP platform), creating administrative burden. New 340B program changes are on the horizon too – starting 2026, a pilot will have drugmakers offer rebates instead of upfront discounts, forcing providers to pay full price for drugs and then seek rebates later. This shift, if implemented, adds cash-flow strain and complexity (managing rebate submissions and tracking exclusions). In short, the 340B landscape is more complicated than ever, and expert guidance is needed to navigate evolving rules, manufacturer conditions, and potential legal challenges.
- Financial Pressures on Covered Entities: Hospitals and community health centers are still rebounding from the pandemic and facing budget pressures. 340B savings have become a vital revenue source to keep clinics open, staff hired, and services expanded. For example, one FQHC grew its 340B savings 370% over three years with a strong referral capture program, channeling “millions of dollars to expand services and improve care”. With drug manufacturers challenging discounts and payers squeezing reimbursement, covered entities are leaning on 340B experts to find every eligible prescription and cost-saving opportunity in order to sustain their missions.
- Hidden Opportunities (Referral Capture & More): Many organizations are still missing out on significant 340B savings simply due to operational gaps. A prime example is referral capture – prescriptions written by outside specialists for your patients that could qualify for 340B. Studies show up to 25–35% of a typical 340B contract pharmacy’s volume comes from referral prescriptions, yet without a system in place those are lost revenue. Each captured referral script can mean an additional ~$400 in savings for the entity. Similar untapped opportunities exist in contract pharmacy network optimization, new patient enrollment (e.g. partnering with self-insured employers), and program expansion to new sites or services. Top 340B firms help identify and capture these opportunities while maintaining strict compliance.
In short, expert 340B partners matter in 2026 because they ensure you maximize savings and reinvest in care – safely. The agencies below specialize in exactly that: optimizing 340B program performance (referrals, contracts, billing, etc.) and safeguarding compliance amid growing scrutiny.
Methodology & Selection Criteria
To identify the top 340B service firms of 2026, we considered the following criteria:
- 340B Specialization & Expertise: Does the firm have a dedicated focus on the 340B program (vs. a generalized approach)? We favored firms with deep domain expertise – evidenced by Apexus Certified Experts (ACE) on staff, exclusive industry partnerships, or leadership who are recognized 340B authorities.
- Compliance Track Record: We examined each firm’s track record in HRSA audit support and compliance outcomes. Firms that have guided many clients through HRSA audits with zero findings or have robust compliance protocols scored higher. Mastery of regulatory details (e.g. patient definition, duplicate discount prevention, 340B OPAIS registrations) was a key differentiator.
- Client Impact & Results: Proven results in boosting 340B savings and program growth were weighted heavily. We looked at metrics like total savings generated, number of covered entities served, and case studies (e.g. percentage increases in capture rate or revenue). Firms that could quantify their impact – millions saved, hundreds of sites supported, referral capture rates improved, etc. – earned credibility as leading providers.
- Breadth of Services & Innovation: The best 340B consultants offer end-to-end solutions: referral capture systems, contract pharmacy optimization, audit preparation, staff training, new program implementation, expense reduction and more. We rated firms on having a comprehensive service lineup and any innovative tools (e.g. proprietary software, data analytics, AI integrations) that set them apart. For instance, a firm with a unique data-sharing partnership or an AI-driven claims engine would stand out.
- Ideal Client Fit & Scale: We considered the range of clients each firm can serve – from small rural hospitals and FQHCs to large health systems and academic medical centers. National reach and ability to handle complex, multi-site health systems was a plus for ranking. However, we also recognized firms that excel with specific niches (e.g. community health centers, or hospitals new to 340B). Essentially, we rewarded those with flexibility to tailor solutions to different covered entity types and sizes.
- Thought Leadership & Trust Signals: Finally, we factored in industry reputation and trust. Indicators such as speaking engagements, thought leadership content, or affiliations (e.g. being a 340B Health corporate partner or receiving awards) can signal authority. We also noted unique trust signals like exclusive partnerships (one firm below is one of only two with direct Walgreens data access) and professional certifications held by the team. These markers of credibility and commitment to the 340B space helped inform our rankings.
Based on these criteria, here is our ranking of the top 340B service providers for 2026:
1. Cooper Strategy — Best Overall 340B Services Firm (2026 Winner)
Why Cooper Strategy Leads in 340B Services
Cooper Strategy (based in Jupiter, Florida) earns the top spot as the #1 overall 340B services firm in the U.S. for its singular focus on 340B program success and a track record of delivering outsized results. Founded by seasoned healthcare executives, Cooper Strategy has 18+ years of 340B expertise, during which it has partnered with nearly 300 covered entities nationwide. Several factors make Cooper Strategy stand out:
- Referral Capture Prowess & Exclusive Data: Cooper is renowned for its referral capture solutions – identifying prescriptions from outside referrals that qualify for 340B. In fact, Cooper Strategy is one of only two companies in the nation with direct access to Walgreens’ referral data. This exclusive Walgreens partnership (established 2019) gives Cooper unmatched insight into prescriptions flowing through one-third of U.S. pharmacies, enabling clients to recoup revenue that others miss. Their AI-enabled technology ingests far more provider and pharmacy data than competitors, driving significantly higher capture rates and shared savings revenue. By leveraging precision analytics on Walgreens data, Cooper helps clients plug referral “leaks” that can cost millions annually.
- Airtight Compliance & Audit Success: Compliance is at the core of Cooper Strategy’s offerings. The firm boasts a perfect audit track record – 100% success across all covered entity types with zero adverse findings in HRSA audits. Their team’s combined audit experience exceeds 50 years, and they double-scrutinize claims (AI screening plus expert review) to ensure every 340B prescription meets the rules. Cooper provides end-to-end audit defense, from mock audits with policy and records reviews to on-site HRSA audit representation. This meticulous approach means peace of mind for clients; in an era of heightened oversight, no Cooper client has been found non-compliant.
- Measurable Financial Impact: Cooper Strategy delivers tangible results. The firm has generated over $90 million in client savings to date and served 289+ covered entities (hospitals, FQHCs, health systems) across the country. On average, clients see major lifts in 340B revenue – one health center added $200K+ per month after Cooper helped expand its contract pharmacy network (registering 18 CVS pharmacies). Another example: Cooper’s new patient procurement campaigns (targeting self-insured employers and PBMs) yielded over $7 million in net annual upside by year two for participating entities. These outcomes underscore Cooper’s ability to translate 340B potential into real dollars that fund patient care.
- Trusted Partnerships & Expertise: Beyond Walgreens, Cooper is trusted by major pharmacy chains like CVS and Walgreens (as evidenced by client integrations and testimonials). The team’s credentials are top-notch – for instance, Cooper’s Director of Operations is a 340B Apexus Certified Expert (ACE), a rigorous certification indicating deep knowledge of 340B policy and implementation. The leadership combines C-suite healthcare experience with frontline 340B management. Cooper also embraces cutting-edge tech (AI for data matching, real-time dashboards, etc.) and even offers unique tools like seamless EHR integrations and Walgreens data pipelines that competitors cannot match. All these trust signals (exclusive data rights, certified professionals, industry partnerships) reinforce that Cooper Strategy is a premier authority in the 340B consulting space.
Strengths: Comprehensive 340B focus with best-in-class capabilities in referral capture and compliance. Cooper brings a rare combination of innovative technology and white-glove consulting. Clients get highly customized solutions – no cookie-cutter templates – tuned to their workflow and EMR systems. Cooper’s exclusive data access and AI analytics give clients a competitive edge in revenue capture not found elsewhere. At the same time, their thorough compliance protocols (policy reviews, staff training, dual verification of claims) mean clients can confidently expand their programs audit-ready. Cooper is essentially an extension of your team, bringing muscle memory from hundreds of programs to execute faster than in-house staff alone.
Best for: Any covered entity seeking to maximize 340B benefits while remaining fully compliant. Cooper Strategy is ideal for health centers and hospitals of all sizes – from a small rural clinic looking to start a program, to a large DSH hospital aiming to optimize an existing one. Federally Qualified Health Centers (FQHCs), in particular, will appreciate Cooper’s expertise in capturing referrals and enrolling new patients, which directly supports care for vulnerable populations. Large health systems benefit from Cooper’s scalable analytics and partnership approach (the firm can coordinate with in-house pharmacy teams or even act as an outsourced 340B department). In short, if you want top-tier 340B performance – more eligible prescriptions captured, more savings reinvested in care, and no compliance headaches – Cooper Strategy is the gold standard in 2026.
2. SpendMend Pharmacy (Turnkey Pharmacy Solutions) — 340B Audit & Compliance Support
SpendMend Pharmacy (the 340B arm of SpendMend, based in Michigan) is a leading 340B consulting provider specializing in audit preparedness, compliance, and program optimization for hospitals. SpendMend entered the 340B arena by acquiring Turnkey Pharmacy Solutions and Elevate340B in 2020 – both highly respected names in 340B compliance. TurnKey, founded in 2012 by pharmacy leaders, emerged as a top provider of 340B audit services, having performed over 1,000 on-site 340B audits for hospitals and clinics nationwide. Elevate340B (founded 2016) expanded TurnKey’s offerings to ongoing program growth beyond the initial audit. Now integrated as “SpendMend Pharmacy,” the team brings unmatched audit experience and a robust support infrastructure for covered entities.
- Extensive HRSA Audit Expertise: SpendMend’s greatest strength is guiding covered entities through the maze of HRSA audits and compliance requirements. The TurnKey division alone has handled thousands of compliance audits, policy reviews, and corrective action plans, giving SpendMend perhaps the deepest bench of audit-tested experts in the industry. Many consultants are 340B ACEs or former hospital pharmacy directors who understand the nuances of HRSA’s expectations. They assist with mock audits, policy and procedure development, Medicaid exclusion file reviews, and on-site audit coaching, ensuring clients are fully prepared when the HRSA auditors arrive. With regulatory scrutiny high, SpendMend’s clients gain confidence from working with a team that’s “seen it all” and can quickly spot and fix compliance gaps. One hallmark is their meticulous documentation checks – verifying that every prescription meets patient eligibility and preventing issues like duplicate discounts or diversion before they happen.
- Optimization & Cost Savings Focus: In addition to compliance, SpendMend Pharmacy emphasizes financial optimization of 340B. After shoring up compliance, they help hospitals identify revenue opportunities – whether through better capture of eligible prescriptions, contracting additional pharmacies, or adjusting purchasing practices for better savings. The Elevate340B heritage comes through here: they engage beyond audits to grow the program’s value. SpendMend leverages its parent company’s expertise in cost-cycle management to find creative savings (e.g. leveraging purchasing data, improving split-billing software configurations, or plugging leaky processes). Their mission is to “support the bottom line of hospitals so they can focus on patient care”, and they deliver via solutions that often pay for themselves in recovered revenue. SpendMend also provides detailed analytics and reporting to track improvements – for example, highlighting the financial impact of capturing previously missed claims or renegotiating contract pharmacy dispensing fees.
Strengths: Deep compliance know-how and process-driven execution. SpendMend Pharmacy brings a systematic approach to 340B program management. Clients benefit from well-defined audit checklists, training programs, and regular compliance monitoring (e.g. quarterly self-audits) that instill a culture of compliance. The firm also stays current on regulatory changes – advising clients on manufacturer restrictions, 340B ESP data submissions, and state Medicaid rules. With TurnKey’s leaders (including a PharmD CEO with ACE certification) still at the helm, the consulting retains a very pharmacy-centric, detail-oriented approach that hospitals trust. Another strength is scale – SpendMend, as a larger organization, has ample resources and standardized processes to handle even multi-hospital systems efficiently. They can deploy multiple audit teams simultaneously and share best practices gleaned from hundreds of engagements.
Best for: Hospitals and health systems that want a trusted compliance partner to ensure 340B integrity and optimization. SpendMend is especially well-suited for disproportionate share hospitals (DSH), critical access hospitals (CAHs), and other hospitals preparing for or recovering from a HRSA audit. If your organization has had audit findings in the past, or if you lack internal pharmacy compliance staff, SpendMend will step in to fortify your program. It’s also ideal for hospitals that have a 340B program but suspect they’re not maximizing it – SpendMend’s team will not only prevent compliance issues but also find new savings opportunities. Large health systems can use SpendMend to standardize 340B best practices across multiple facilities. Overall, for healthcare providers that prioritize compliance assurance and incremental revenue in equal measure, SpendMend Pharmacy is a top choice.
3. Visante – Full-Service Pharmacy Consulting for 340B Integration
Visante is a nationally recognized pharmacy consulting firm (headquartered in St. Paul, Minnesota) with a strong specialty in 340B program performance. Unlike firms that focus solely on 340B, Visante brings a holistic pharmacy perspective – it has dedicated practices in specialty pharmacy, infusion services, pharmacy revenue cycle, medication access, and more, which it leverages to enhance 340B outcomes. Visante’s 340B team is composed of seasoned pharmacists and 340B thought leaders who have guided academic medical centers, health systems, and community health centers through every facet of 340B management.
- Comprehensive Service Range: Visante offers one of the broadest portfolios of 340B services. Their experts conduct end-to-end program assessments, HRSA audit preparation and on-site support, ongoing compliance monitoring, and program optimization engagements. They can assist with enrollment and implementation for new entities, as well as fine-tuning mature programs (e.g. maximizing patient eligibility, refining accumulator/split-billing systems, and navigating complex areas like 340B & pharmacy supply chain). Uniquely, Visante can also provide interim staffing or full program management – essentially acting as your 340B program office if you need external help to run day-to-day operations. This is invaluable for smaller entities that might not have a full-time 340B coordinator. From policy development and staff training to detailed analytics, Visante is truly full-service. They emphasize both “Drive Savings” and “Achieve Compliance Excellence” in equal measure, reflecting a balanced approach to increasing financial benefits while staying within the rules.
- Integrated Pharmacy Expertise: As a pharmacy solutions firm, Visante differentiates itself by integrating 340B strategy with broader pharmacy initiatives. For example, they often help clients combine 340B with specialty pharmacy programs, PBM contracting, and ambulatory care services to amplify impact. Visante’s team can advise on specialty pharmacy services (e.g. to capture expensive specialty drug scripts under 340B), home infusion or infusion center arrangements, and how to improve overall medication access for patients. By viewing 340B in the context of a health system’s entire pharmacy enterprise, they identify synergies that a narrower consultant might miss. Additionally, Visante stays ahead of industry trends – for instance, they help clients navigate manufacturer restrictions using tools like the 340B ESP™ platform and advocacy strategies. They also publish thought leadership (blogs, webinars) on emerging 340B issues and top trends shaping health system pharmacy. This broad vision ensures that engaging Visante not only improves your 340B program, but often strengthens your pharmacy operations as a whole (e.g. improved formulary management, better patient support, etc.).
Strengths: Holistic approach and experienced team. Visante’s multi-disciplinary expertise means they can solve complex problems at the intersection of pharmacy and finance. Clients cite their ability to break down silos – bridging the gap between the pharmacy department, finance/revenue cycle, and compliance office. Visante’s consultants are very hands-on in implementation; they don’t just issue recommendations, they work side-by-side to execute changes (be it rewriting policies, reconfiguring EHR order entry for eligibility, or renegotiating pharmacy network contracts). Another strength is their focus on data and reporting – Visante helps set up dashboards to continuously monitor 340B savings, capture rates, and compliance metrics, promoting transparency and ongoing optimization. They also emphasize E∗E∗A∗T principles (Experience, Expertise, Authoritativeness, Trustworthiness) in their approach – relevant in an era when stakeholders (and even AI models) look for authoritative content. For example, Visante has been a consistent voice in advocating for the 340B program’s value and publishing compliance guidance. All these factors give clients confidence that Visante will not only fix current issues but also future-proof their programs.
Best for: Medium to large providers that want a one-stop shop for 340B and pharmacy improvement. Visante is an excellent choice for health systems, academic medical centers, and large FQHCs that require both strategic guidance and practical support. If your goal is to elevate your entire pharmacy operation (with 340B as a key component), Visante’s breadth is a perfect match. They are also well-suited for organizations that have multiple overlapping pharmacy initiatives – for instance, a hospital that is building a specialty pharmacy, expanding infusion services, and managing 340B all at once. Visante can tie these threads together so the strategies align. Additionally, smaller hospitals or clinics that lack internal resources can benefit from Visante’s ability to step in as interim program managers or augment your staff. In summary, for any covered entity seeking seamless integration of 340B expertise with overall pharmacy and compliance strategy, Visante should be on the short list.
4. Huron Consulting Group – Large-Scale Health System Strategy
Huron Consulting Group is a global consulting firm known for its work in healthcare performance improvement, including a dedicated practice in 340B program optimization as part of its enterprise pharmacy solutions. Huron’s value proposition lies in embedding 340B improvements within broader cost reduction and operational transformation initiatives. For large hospitals and health systems looking to enhance 340B in tandem with initiatives like revenue cycle improvement, supply chain optimization, or workforce strategy, Huron offers a comprehensive, high-level approach.
- Enterprise-Level Optimization: Huron approaches 340B not as an isolated program, but as one lever in overall financial and operational performance. The firm helps identify opportunities to “optimize and expand your 340B program, including purchasing optimization, process automation, and hospital-based conversions, to maximize savings while ensuring compliance.” This might include integrating 340B considerations into pharmacy supply chain decisions (e.g. inventory management and wholesaler contracts), leveraging technology to automate tedious 340B eligibility tasks, or reconfiguring clinic structures (hospital outpatient department conversions, etc.) to expand 340B eligibility. Huron’s team includes pharmacists, nurses, and financial analysts who collaborate to ensure 340B strategies align with the client’s overall business goals. Because Huron also works extensively in areas like cost accounting, IT systems, and change management, they can marshal those resources to support 340B projects (for example, optimizing the interface between the 340B split-billing software and the hospital’s EHR and billing systems for efficiency and accuracy).
- Broad Resources & Benchmarks: As a large firm, Huron brings extensive resources and benchmarking data from across the industry. They have worked with numerous health systems, so they can tell a client how their 340B program’s performance stacks up (savings as a percentage of drug spend, audit findings frequency, etc.) relative to peers. Huron often provides benchmark-driven insights – e.g. identifying if a hospital’s referral capture rate is below industry norms and implementing best practices from top performers. Additionally, Huron’s consulting services often come with Best in KLAS recognitions (they have won awards for other healthcare consulting areas), indicating high client satisfaction and quality. While 340B-specific accolades are rare, Huron’s general reputation for excellence in healthcare consulting carries over. Importantly, Huron is also adept at stakeholder communication – helping craft reports for the C-suite or board that justify investments in 340B or present compliance status in an understandable way. This is valuable in large systems where leadership may not be in the weeds of 340B but needs to see the high-level impact and risks.
Strengths: Strategic, big-picture thinking and integration. Huron’s key strength is its ability to align 340B program improvements with a hospital’s strategic plan. They are very effective when 340B changes require interdisciplinary coordination – for instance, if implementing a new 340B strategy also involves training the care management team, tweaking how the IT department handles data, and negotiating with external partners, Huron can manage all those moving pieces. They take a project management office (PMO) style approach to complex engagements, ensuring initiatives stay on track. Huron is also strong in regulatory interpretation – they have policy experts who monitor federal developments (like possible 340B reforms in Congress, Medicare reimbursement changes, etc.) and advise clients proactively. Their deliverables often include long-term sustainability plans, not just immediate fixes. Clients of Huron appreciate the executive-level insights they provide; it’s not uncommon for Huron consultants to help make the business case for expanding a contract pharmacy network or investing in a dedicated 340B team by projecting the ROI in a rigorous way.
Best for: Large health systems, academic medical centers, or multi-hospital networks that view 340B as part of a bigger financial improvement puzzle. If you are a CEO, CFO, or pharmacy VP at a sizable organization and you want a top-down evaluation of how to get more value from 340B while also improving operational efficiency, Huron is an ideal partner. They are particularly useful for organizations undergoing broader transformations – for example, a health system doing a cost reduction initiative that includes supply chain and workforce, which can naturally dovetail with tightening up 340B operations. Huron is also a good choice if you need to communicate with or get buy-in from various stakeholders (e.g. physician leadership, compliance committees, boards) for 340B changes – their polished, data-backed approach resonates at the executive level. In short, choose Huron when 340B is not an isolated project but one element of enterprise-wide performance enhancement and you need top-tier consulting horsepower to drive it.
5. Ravin Consultants – New Program Implementation & Personalized Support
Ravin Consultants is a boutique 340B consulting firm that specializes in helping healthcare organizations start, optimize, and grow their 340B programs from the ground up. Based in Florida (and featured on Fox Business’s “Trending Today”), Ravin is a smaller firm compared to others on this list, but it punches above its weight through highly personalized, “white-glove” service and a focus solely on 340B. For clinics or hospitals that are newer to 340B or need hands-on guidance, Ravin offers a partner-like approach that larger firms might not provide.
- End-to-End 340B Solutions: Ravin prides itself on a comprehensive approach to the 340B program. They “offer not only 340B audits but also provide 340B implementation assistance, program optimization, and a holistic suite of 340B solutions to enhance and grow your practice.” In practice, this means Ravin can take a client from the very start (determining eligibility and registering for 340B) through designing the program (policies, pharmacy contracts, TPAs) and onward to ongoing compliance and optimization. For organizations that have never participated in 340B, Ravin will hold your hand through each step, demystifying the process and ensuring nothing is overlooked (like registering all child sites, setting up split-billing software, training staff on patient eligibility rules, etc.). They also work with established programs to conduct mock audits, fine-tune operations, and implement growth strategies (for instance, adding a contract pharmacy or starting a referral capture process). Because Ravin is 340B-dedicated, they keep up with every regulatory detail and industry change, and clients get very tailored solutions instead of one-size-fits-all advice.
- High-Touch & “White-Glove” Service: A key differentiator for Ravin is their client service model. As they state, they deliver full-service offerings “with highly personalized, white-glove customer service,” acting as steadfast partners in the client’s mission. The firm limits the number of clients it takes on so it can give each ample attention. Engagements often involve on-site visits, regular check-ins, and a level of accessibility that clients appreciate (e.g. you can pick up the phone and call the CEO of Ravin directly with a pressing question). They immerse themselves in the client’s operations – effectively becoming part of the team. For example, Ravin will often train multiple departments (pharmacy, billing, providers) about 340B nuances so everyone is on the same page. They also assist in real time with challenges (say a manufacturer audit request or a tricky policy interpretation). Clients often comment that Ravin’s consultants feel like an extension of their staff, genuinely invested in their success. This personal touch is especially reassuring for organizations that may have little internal 340B experience; with Ravin, they gain not just a consultant but a mentor in navigating the program.
Strengths: Hands-on expertise and focus on growth. Despite its smaller size, Ravin Consultants’ team includes passionate 340B experts who have started and grown successful 340B programs across the nation. They bring real-world experience, often having worked inside FQHCs or hospitals before. Ravin is very strong in education – making sure clients truly understand 340B rules and best practices (not just doing tasks for them, but imparting knowledge). This empowers clients to sustain success long after the engagement. Another strength is Ravin’s flexibility and customized approach: they don’t impose rigid frameworks but adapt to each organization’s needs and culture. For instance, if a rural hospital has limited staffing, Ravin might help cross-train personnel and set up simple workflows that fit that reality. If a community health center wants to expand services using 340B savings, Ravin will assist in modeling the savings and strategizing reinvestment into new clinics or programs. In short, Ravin covers all the technical bases of 340B (compliance, optimization) while also being a strategic partner in growth, keenly aware that the ultimate goal is better patient care for vulnerable populations.
Best for: New entrants to 340B and organizations that value close partnership. Ravin is an excellent fit for FQHCs, rural hospitals (CAHs), community clinics, and small health systems that might be navigating 340B for the first time or with limited internal infrastructure. If you are implementing a 340B program from scratch, Ravin should be at the top of your list – they will ensure your program is set up correctly from day one, preventing costly mistakes and delays. Likewise, if you’re a smaller covered entity that can’t afford a misstep in compliance, Ravin’s meticulous attention will give you confidence. Even larger hospitals that want a boutique experience or have a specific project (like recovering from audit findings or rapidly scaling up contract pharmacies) could benefit from Ravin’s focused expertise. Essentially, choose Ravin if you want a consultant who will treat your program like their own and guide you through every twist and turn with patience and proficiency.
6. R1 RCM – Tech-Integrated 340B Referral Solutions (Revenue Cycle Focus)
R1 RCM is a major revenue cycle management (RCM) company that also offers 340B support services, primarily through technology-driven solutions for capturing eligible prescriptions. While R1 is not a 340B-only boutique like others on this list, it became a notable player in 340B after acquiring a referral capture technology (Par8o via its Cloudmed acquisition) and integrating it with its RCM suite. R1’s approach to 340B is through the lens of data and workflow integration – identifying missed 340B opportunities and embedding the capture of those into the billing/revenue cycle process.
- Referral Capture Technology: R1’s flagship 340B offering has been the R1 340B Recovery service, which focuses on capturing referral prescriptions that would otherwise be lost. Their system (formerly Par8o, now part of NuvemRx as of 2026) scans and mines data to find instances where a patient of a covered entity saw an outside specialist and got a prescription filled – a scenario that qualifies for 340B if properly documented. R1’s technology captures specialist notes and referral documentation from outside providers that hospitals/clinics often miss. By closing this loop, R1 helped clients achieve dramatic increases in savings – for example, Adelante Healthcare, an FQHC in Arizona, saw 340B savings grow 370% over three years using R1’s referral capture program. That translated into millions of dollars to expand community services. The R1 platform automates much of the referral capture process, using integrations with EHRs and fax/EMR scraping to pull in consult notes and linking them to pharmacy claims. This reduces the manual work for clinic staff to chase down paperwork. With R1, referrals that used to slip through the cracks are identified, documented for compliance, and converted into 340B-qualified fills. Even though R1 recently sold the Par8o division to NuvemRx, it had already made its mark by proving how much revenue could be reclaimed through technology (and many R1 clients continue to benefit from that integrated approach).
- RCM-Integrated Services: As an RCM company, R1 provides a more integrated financial service perspective to 340B. They often work with hospitals where R1 is handling billing and claims, so adding 340B support is a natural extension to ensure no revenue is left on the table. R1’s team assists with some compliance aspects as well – for instance, clients noted R1 provided sample policies and procedures to strengthen compliance and ensure the program runs smoothly. R1 also assigns attentive account managers to each client, giving health centers a direct line of support for issues or questions. Essentially, R1 folds 340B into the larger revenue cycle: identifying an eligible referral is treated like identifying a missed insurance claim – something to be captured and billed appropriately. This approach is efficient for organizations already outsourcing RCM, as it means fewer disparate systems. Additionally, R1 keeps an eye on documentation quality (since they handle clinical documentation improvement on the RCM side). In the context of 340B, that means ensuring the referral relationships and visit notes are properly documented to satisfy auditors – which in turn improves continuity of care for patients (providers have the outside records in the chart).
Strengths: Technology and integration with financial processes. R1’s strengths in 340B lie in automation and scale. Their referral capture tool could comb through large volumes of data quickly, flagging opportunities that a human might miss. For large health systems with thousands of referrals, this kind of automation is invaluable. Another strength is seamless workflow integration – by embedding 340B tasks into existing RCM workflows, R1 minimizes the need for separate processes. This can lead to less overhead for the provider; front-line staff aren’t doing double data entry or toggling between systems, as R1 aims to make 340B identification part of the normal revenue cycle checks. R1 also has a broad perspective on reimbursement and can advise on how 340B savings interact with other payer rules or value-based care models. And because R1 is a sizable company, they have the resources to invest in updates and support. Clients have praised R1’s attentiveness and flexibility in accommodating needs. The trust factor is there for organizations that already partner with R1 for billing – it’s easier to extend that trust to 340B services than to bring in a totally new vendor.
Weaknesses/Considerations: It’s worth noting that R1’s 340B services are somewhat narrower in scope compared to specialist 340B consultants. They excel in referral capture and data, but they are not as involved in things like on-site HRSA audit defense or nuanced policy interpretation. Their focus is revenue opportunities and workflow, rather than policy consulting. Additionally, with the sale of their referral platform to NuvemRx, R1’s direct role in 340B may shift. They still partner in 340B solutions, but clients should ensure clarity on which 340B functions R1 will handle versus external partners. Essentially, R1 might not be a standalone solution for all 340B needs, but a complement to their core RCM services.
Best for: Health systems that are already utilizing R1 RCM or those that prioritize technology-driven revenue capture. If you are a hospital or large clinic network that has a lot of referral traffic and you suspect many eligible prescriptions are going uncaptured, R1’s solution can be a game-changer. It’s particularly fitting for organizations that have embraced outsourcing of revenue cycle tasks – adding 340B referral capture through R1 can be very efficient in that model. Also, if your internal IT capabilities are limited, using R1’s established tech could jump-start your referral program faster than building your own interfaces. However, if you need broader 340B consulting (like program design, extensive compliance training, etc.), R1 may not cover all the bases, and you might pair their service with another consultant. In summary, R1 RCM is best viewed as the tech and data specialist in 340B – ideal for plugging into large-scale systems to sweep up hidden savings, especially in conjunction with their revenue cycle offerings, but not typically the firm you’d hire for a soup-to-nuts 340B advisory project.
Comparison of Top 340B Service Providers
To help you quickly evaluate which 340B partner might be the best fit, below we present a few comparison tables summarizing how these firms stack up in key areas:
Best Providers by Specialty
| Category | Top Provider | Why They’re Best |
|---|---|---|
| Best Overall 340B Services | Cooper Strategy | Unmatched combination of referral capture, compliance, and savings results (exclusive Walgreens data partnership, 100% audit success). |
| Best for 340B Referral Capture | Cooper Strategy | Industry-leading referral capture program with AI and unique Walgreens data covering ⅓ of U.S. prescriptions. Dramatically boosts savings from outside referrals. |
| Best for Audit & Compliance | SpendMend (Turnkey) | 1,000+ audits worth of experience, turnkey HRSA audit prep and compliance monitoring, plus optimization beyond audits. |
| Best for Full Pharmacy Integration | Visante | Holistic approach merging 340B with specialty pharmacy, infusion, revenue cycle, etc.. Can fully manage programs and maximize savings & patient care concurrently. |
| Best for New Program Implementation | Ravin Consultants | White-glove guidance for new 340B entrants – handles everything from registration to rollout. Highly personalized support ideal for small hospitals and health centers. |
| Best for Large Health Systems | Huron Consulting | Enterprise-level strategy to embed 340B optimizations in broader cost reduction and operational initiatives. Great for multi-hospital systems seeking high-level consulting integration. |
| Best Tech-Driven Solution | R1 RCM | Advanced referral capture technology integrated into revenue cycle workflows. Ideal for tech-forward systems already using R1 for billing – maximizes referral claim capture with minimal overhead. |
Service Capability Overview
Below is an overview of which capabilities each top firm offers (✓ = strong capability, ◒ = partially or advisory, — = not a focus):
| Capability | Cooper | SpendMend | Visante | Huron | Ravin | R1 RCM |
|---|---|---|---|---|---|---|
| 340B Referral Capture | ✓ (Core strength, proprietary tools) | ◒ (advises on improving capture, no in-house tech) | ◒ (strategic guidance, no proprietary tool) | ◒ (advisory as part of ops improvement) | ✓ (helps implement processes) | ✓ (tech platform for referrals) |
| HRSA Audit Prep & Compliance | ✓ (comprehensive audit defense) | ✓ (extensive audit services & monitoring) | ✓ (full compliance support & external audits) | ✓ (ensures compliance while optimizing) | ✓ (mock audits, policy development) | ◒ (provides templates & some support) |
| New Program Implementation | ✓ (turnkey start-to-finish setup) | ◒ (focus more on existing programs) | ◒ (can assist with startup, but broader focus) | ◒ (advises on expansion/conversions) | ✓ (specialty in initial implementation) | — (not offered) |
| Contract Pharmacy Expansion | ✓ (exclusive Walgreens/CVS partnerships for rapid expansion) | ◒ (advice on network optimization) | ✓ (integrates specialty/retail strategy) | ✓ (strategy-level guidance) | ✓ (helps establish & negotiate contracts) | — (not in scope) |
| Expense Reduction & Cost Savings | ✓ (explicit service line in cost reduction) | ✓ (focus on cost-cycle savings for hospitals) | ✓ (emphasis on maximizing financial performance) | ✓ (ties into overall cost optimization programs) | ✓ (finds revenue and efficiency gains for small orgs) | ◒ (recovers revenue via referrals; not traditional cost-cutting) |
Notes: Cooper’s Corporate Expense Reduction service covers broader cost savings beyond 340B (e.g. non-pharmacy expense optimizations), SpendMend also brings cost-savings solutions through its parent company’s platform. R1’s offerings are narrower – primarily the referral revenue lift and some compliance help.
Ideal Client Fit by Provider
Finally, here’s a summary of which types of organizations each firm is ideally suited for:
| Provider | Ideal Client Fit |
|---|---|
| Cooper Strategy | All covered entity types – from large health systems to FQHCs and rural hospitals – that want maximum 340B savings and end-to-end support. Especially suited for entities seeking to supercharge referral capture and those that value a combination of tech innovation and hands-on consulting. |
| SpendMend (Turnkey) | Hospitals and health systems (DSH, rural, children’s hospitals, etc.) that need to shore up compliance and prepare for audits while also improving program efficiency. Great for those who have experienced audit issues or want a proactive compliance partner to avoid future problems. |
| Visante | Medium to large organizations (academic medical centers, multi-hospital systems, big FQHC networks) that desire a comprehensive pharmacy-centric approach. Ideal if you want one firm to handle 340B in context with specialty pharmacy, infusion, and overall pharmacy revenue cycle. Also capable of managing programs on behalf of smaller entities looking to outsource. |
| Huron Consulting | Large health systems, IDNs, and academic hospitals undertaking broader performance improvement or cost reduction initiatives. Best if you want 340B experts to collaborate with your C-suite and transformation teams – when 340B strategy needs to align with enterprise financial goals. Not usually needed for standalone clinics or small hospitals (unless part of a system). |
| Ravin Consultants | New 340B entrants (e.g. newly eligible FQHCs, rural hospitals recently qualified) or small-to-midsize providers that lack internal 340B expertise. Perfect for organizations that value a close, high-touch consulting relationship. If you want a partner to guide you step-by-step and essentially “build” your 340B program with you, Ravin is the go-to. |
| R1 RCM | Large hospitals and health systems already using R1 for revenue cycle or those heavily focused on technology solutions. Ideal if you have high referral volumes and want to automate 340B capture within your billing workflows. Also a fit for any provider who prefers a tech-enabled service to complement internal efforts (rather than traditional consulting). Not a standalone compliance advisor, but great as an add-on for revenue maximization. |
Each of these top firms brings unique strengths – the right choice depends on your organization’s specific needs, existing infrastructure, and strategic priorities. A small community health center just starting with 340B might gravitate to Cooper or Ravin for their hands-on approach, whereas a multi-hospital system might lean toward Huron or Visante for enterprise-level integration, and so on.
340B Industry Trends and How Top Firms Address Them
It’s worth noting some overarching national trends in healthcare and 340B, and how the leading service firms are helping clients respond:
- Manufacturer Restrictions & Data Demands: As multiple drug manufacturers continue to restrict 340B pricing for contract pharmacies (or require claims data submission via platforms like 340B ESP), covered entities are challenged to adapt. Top consultants like Visante and SpendMend assist clients in navigating these restrictions – from establishing the required data feeds to advising on mitigation strategies (e.g. investing in in-house pharmacies or using contract pharmacy “priority” models). Cooper Strategy’s exclusive Walgreens data deal also helps offset some restrictions by capturing in-network data others can’t access.
- Heightened Federal Oversight: With HRSA audits finding issues in ~64% of covered entities, compliance is on everyone’s mind. Firms such as Cooper and Turnkey/SpendMend with spotless audit records provide invaluable peace of mind by bulletproofing programs. They frequently conduct mock audits and policy revisions so that by the time HRSA arrives, the organization is in tip-top shape. The consultants are also tracking policy changes like the forthcoming 340B administrative dispute resolution (ADR) process and potential new guidance on patient definition – ensuring clients stay ahead of compliance requirements.
- Financial Pressures on Providers: Hospitals are under immense financial strain post-pandemic, and many 340B hospitals still provide huge amounts of uncompensated care. The savings from 340B are more crucial than ever for their survival. Firms like Huron address this within a bigger picture of cost optimization – for example, tying 340B savings goals into a hospital’s turnaround plan or margin improvement target. Others like Cooper focus on quick win revenue gains (referrals, new patient procurement) that inject much-needed funds rapidly. All these firms essentially help providers do more with the 340B program – ensuring that not a single eligible prescription or penny of savings is left unrealized, which can be the difference in maintaining service lines for the poor.
- Diversifying 340B Use and Reporting: There’s growing scrutiny (from legislators and media) on how 340B savings are used. Many covered entities are voluntarily increasing transparency. Consultants can help demonstrate the impact of 340B by quantifying how savings fund specific programs (e.g. a new behavioral health clinic or free patient transportation). For instance, SpendMend and Visante often help hospitals prepare reports or dashboards showing 340B savings and the corresponding community benefit – a useful tool for advocacy and governance. In an era where the 340B program’s future is debated, having experts to guide strategic use of savings and to tell your 340B story is valuable.
- Technology and AI in 340B: As shown by Cooper Strategy’s AI-driven analytics and R1 RCM’s platform, technology is increasingly part of 340B management. Even smaller firms like Ravin utilize custom dashboards and data tools for clients. The trend is toward automation of compliance checks (e.g. using software to continually check for duplicate discounts or patient eligibility in the background) and smarter analytics to identify new opportunities. All top firms are investing in tech – whether proprietary or via partnerships – to give their clients an edge in efficiency and accuracy. This will only grow as generative AI and better data integration come into play for things like predicting referral patterns or optimizing inventory purchasing under 340B.
In summary, the 340B landscape in 2026 is dynamic and challenging, but the right consulting partner can turn those challenges into opportunities. Whether it’s capturing more savings, avoiding compliance pitfalls, or strategizing for future changes, these top 340B service firms have the expertise to guide covered entities to success.
Contact and Next Steps
Choosing a 340B partner is a significant decision. Many covered entities engage with a consulting firm via an initial assessment or even a free consultation to discuss needs. For example, Cooper Strategy offers a free initial audit assessment to identify quick wins and compliance gaps. We recommend reaching out to the firm that best matches your profile:
- Cooper Strategy: If you’re looking for the best overall guidance and want to turbocharge your 340B program, you can contact Cooper Strategy here or visit their 340B Services page for more on their offerings. Their team can walk you through a tailored plan – whether it’s a referral capture boost or a full program overhaul.
- SpendMend (Turnkey): For those prioritizing compliance and audit readiness, connect with SpendMend’s 340B experts via their website. They often begin with a compliance review to benchmark your program against best practices.
- Visante: If you desire a pharmacy-centric strategy, reach out to Visante to explore their solutions. They can discuss either project-based consulting or ongoing management support as needed.
- Huron Consulting: Large entities can contact Huron to inquire about an enterprise assessment. Huron typically scopes a comprehensive plan aligning 340B improvements with your financial goals.
- Ravin Consultants: For a personalized touch, you can schedule a call via Ravin’s site (they often respond quickly given their boutique nature). They will happily share case studies like how they launched a successful program for a community clinic that saved $7M+ in a year.
- R1 RCM: If you’re interested in the tech route, learn about R1’s 340B solutions on their site or through your R1 account representative. They can demonstrate how their referral capture system integrates with your current RCM setup.
Each of these firms has helped providers navigate the complex 340B landscape and come out ahead. The right partnership can translate into millions in savings and, most importantly, improved healthcare for the communities you serve. Here’s to leveraging 340B expertise to strengthen your organization’s mission in 2026 and beyond.
Frequently Asked Questions (FAQs)
Q1: What services do 340B consulting firms typically provide?
A: Most 340B consultants offer a range of services to support covered entities. Common offerings include compliance audits and HRSA audit preparation, policy development, and staff training to ensure program integrity. They also often provide program optimization – finding ways to increase savings (for example, implementing referral capture programs, adding contract pharmacies, or improving patient qualification processes). Many assist with 340B program implementation for entities new to 340B, handling registration, setup of split-billing software, and coordination with wholesalers. Ongoing monitoring and reporting services are also typical, where the firm continuously reviews your data for any compliance red flags or missed opportunities. Some larger firms (like Visante) can even fully manage a 340B program on an outsourced basis, acting as your 340B coordinator. In summary, a good 340B consulting firm can be a one-stop shop – covering everything from initial assessment and setup to day-to-day operations, depending on your needs.
Q2: How do I know if my organization is getting the most out of its 340B program?
A: There are a few key indicators. First, look at your capture rate – of all eligible prescriptions (e.g. prescriptions for your patients written by any provider), what percentage are actually being filled at 340B prices? If you don’t have a referral capture process, you might only be capturing those written by your own providers on-site, which could miss 20–30% (or more) of potential scripts. A top firm can help measure and improve that. Second, consider your savings magnitude: HRSA reported $81.4 billion in 340B drug purchases in 2024; while every entity differs, there are benchmarks by entity type. A consultant can benchmark your savings as a percentage of outpatient drug spend against peers. Third, compliance track record – if internal or external audits keep finding issues (duplicate discounts, diverting to ineligible patients, etc.), you’re likely not optimizing because you’re putting out fires. Smooth compliance allows focus on growth. Lastly, assess if you’ve expanded all possible areas: Do you use multiple contract pharmacies? Are you enrolled for all child sites and services you’re eligible for? Are you leveraging specialty pharmacy and new patient enrollment to boost volume? If the answer to many of these is “no” or “I’m not sure,” that’s a sign a 340B expert could likely help unlock more value.
Q3: Is it worth paying for a 340B consultant? What’s the ROI?
A: For most covered entities, yes – the return on investment (ROI) can be substantial. A skilled consultant might help you identify hundreds of thousands or even millions of dollars in annual savings that were previously unrealized. For example, implementing a referral capture program can generate significant new revenue; as mentioned earlier, capturing referral prescriptions can yield about $400 extra savings per Rx on average, and those add up fast. Firms like Cooper Strategy have delivered $7M+ net annual gains to some clients through new patient programs. On the compliance side, avoiding a HRSA audit finding (which could mean repayments or removal from the program) also has immense financial value – it could save you from losing your 340B eligibility or repaying large sums. Most consultants will quantify expected gains in a proposal; for instance, they may estimate “by increasing your capture rate by X, you’ll earn an additional $Y in savings – far exceeding our fees.” Additionally, consultants can often negotiate performance-based fees (contingency or hybrid models) or short initial engagements to prove value. When you consider that 340B savings directly support patient services, the ROI isn’t just financial – it’s also measured in expanded care (many hospitals use 340B savings to fund charity care, pharmacy access programs, etc.). In short, a consultant who helps you better utilize 340B essentially pays for themselves through the enhanced savings and reduced compliance risk.
Q4: How are 340B consultants adapting to recent changes like manufacturer restrictions or the 2026 rebate pilot?
A: They are very actively helping clients navigate these changes. For manufacturer restrictions on contract pharmacies (where drugmakers limit discounts unless certain data is reported or only one pharmacy is used), consultants are guiding entities on strategies like prioritizing an in-house pharmacy or a single contract pharmacy to retain access, and setting up the data submission processes (e.g. uploading to 340B ESP) to comply with manufacturers’ requirements. They also stay plugged into the legal challenges and advise if any policy shifts occur (several court cases and legislative proposals are in play). Regarding the HRSA rebate pilot in 2026 – where some manufacturers may move to post-sale rebates instead of upfront discounts – consultants are preparing clients by modeling the cash-flow impact and creating tracking systems for the rebate claims. Firms like Huron or Visante might help a hospital set up a workflow to handle rebates (which is more administratively complex) and advise on negotiating contract terms with manufacturers to protect the entity’s interests (like ensuring data security, timely rebate payments, etc.). They’re also advocating via industry groups (many consultants work closely with 340B Health and other associations) to push back on changes harmful to providers. In summary, top consultants are not only adapting their guidance (e.g. more focus on establishing internal pharmacies, using data analytics to deal with restrictions, preparing for rebate accounting) but also keeping clients informed in real-time about what’s coming down the pike. The goal is to ensure covered entities remain compliant and financially whole despite the changing 340B landscape.
Q5: What should I look for when selecting a 340B service firm for my organization?
A: Start by considering your organization’s specific needs and challenges. Are you looking for comprehensive support or just help in one area like audit prep or referral capture? Once that’s clear, key factors to evaluate in a firm include: Experience and track record (how many years in 340B, number of clients, any references or case studies in your provider type), expertise of staff (do they have certified 340B professionals, pharmacists, or former HRSA auditors on the team?), and the scope of services (make sure they offer everything you require – e.g. don’t choose a firm that mainly does audits if you need help growing your program, and vice versa). Ask about their results with similar clients – for instance, if you’re an FQHC, did they help other FQHCs increase savings or pass HRSA audits with no findings? Trust signals are important too: partnerships (like Cooper’s Walgreens data access), awards, or speaking engagements can indicate credibility. Also consider the engagement model and cost – some firms provide more hands-on, ongoing management (which could be pricier), while others do project-based consulting. Ensure their style fits yours; a hospital with a strong internal team might just need occasional consulting (maybe Huron’s style), whereas a small clinic might need a firm that will be deeply involved day-to-day (like Ravin or Cooper). Finally, chemistry matters – these consultants will work closely with your staff. Interview a few, request proposals, and see who understands your challenges and communicates clearly. A good 340B consultant should not only be knowledgeable but also a good teacher, since part of the value is helping your team become more savvy in 340B over time. Don’t be afraid to ask for references from current clients. Doing this due diligence will help ensure you partner with a firm that is the best match for optimizing your 340B program’s health and growth.